...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor.
【24h】

A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor.

机译:一系列新型的哌嗪基-吡啶尿素作为嘌呤能P2Y12受体的拮抗剂。

获取原文
获取原文并翻译 | 示例
           

摘要

A novel series of P2Y(12) antagonists for development of drugs within the antiplatelet area is presented. The synthesis of the piperazinyl-pyridine urea derivatives and their structure-activity relationships (SAR) are described. Several compounds showed P2Y(12) antagonistic activities in the sub-micromolar range.
机译:提出了一系列新的P2Y(12)拮抗剂,用于在抗血小板区域内开发药物。描述了哌嗪基-吡啶脲衍生物的合成及其结构-活性关系(SAR)。几种化合物在亚微摩尔范围内显示P2Y(12)拮抗活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号